Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor

NCT07347132 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.

NCT NCT07347132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07347132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor
Lead sponsor
Lahore General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2024
Completion date
November 30, 2025
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-muscle invasive bladder cancer, urinary bladder neoplasms